Gründer G, Mertens L, Jungaberle A, Jungaberle H, Spangemacher M. Compassionate use of psilocybin for treatment-resistant depression in Germany. Lancet Psychiatry. 2025 Sep 18. [Epub ahead of print]
Ousdal OT, Argyelan M, Laroy M, Anand A, Bouckaert F, Camprodon JA, Cano M, Cardoner N, Dannlowski U, Dols A, Emsell L, Espinoza R, Hebbrecht K, Hurlemann R, Jorgensen M, Kiebs M, Kishimoto T, Narr KL, Nordanskog P, Opel N, Redlich R, Rhebergen D, Sartorius A, Schrijvers D, Sienaert P, Soriano-Mas C, Takamiya A, Ten Doesschate F, Tendolkar I, Urretavizcaya M, van Diermen L, van Eijndhoven P, van Wingen G, van Waarde J, Vandenbulcke M, Verdijk J, Wade BSC, Antoine Y, Brekke N, Prudic J, McClintock S, Kessler U, Bartsch H, Odegaard K, Haavik J, Hammar Å, Abbott C, Oltedal L. Effects of electroconvulsive therapy on hippocampal longitudinal axis and its association with cognitive side effects. Commun Med (Lond). 2025 5(1):409.
Sartorius A, Karl S, Janke C, Beck G. Intersections of Anesthesiology and Psychiatry: Comment. Anesthesiology. 2025 142(3):577-578.
Sartorius A, Kellner CH, Karl S, Espinoza RT. Age and First Seizure Length in Electroconvulsive Therapy. JAMA Netw Open. 2025 8(5):e2512092.
Spangemacher M, Schmitz C, Cumming P, Färber LV, Hart XM, Uchida H, Gründer G. The sense and nonsense of antipsychotic combinations: A model for dopamine D receptor occupancy. Transl Psychiatry. 2025 15(1):348.